TactiCath
Device
Abbott Laboratories
Total Payments
$174,555
Transactions
116
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $83,373 | 67 | 0 |
| 2018 | $91,183 | 49 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $174,555 | 116 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| TactiCath Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study | Abbott Laboratories | $174,555 | 0 |
Top Doctors Receiving Payments for TactiCath
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Flint, MI | $174,555 | 116 |
Ad
Manufacturing Companies
- Abbott Laboratories $174,555
Product Information
- Type Device
- Total Payments $174,555
- Total Doctors 0
- Transactions 116
About TactiCath
TactiCath is a device associated with $174,555 in payments to 0 healthcare providers, recorded across 116 transactions in the CMS Open Payments database. The primary manufacturer is Abbott Laboratories.
Payment data is available from 2018 to 2019. In 2019, $83,373 was paid across 67 transactions to 0 doctors.
The most common payment nature for TactiCath is "Unspecified" ($174,555, 100.0% of total).
TactiCath is associated with 1 research study, including "TactiCath Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study" ($174,555).